Login / Signup
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.
Sol Carriazo
Alberto Ortiz Arduan
Beatriz Fernandez-Fernandez
Published in:
Annals of internal medicine (2023)
Keyphrases
</>
type diabetes
glycemic control
cardiovascular disease
insulin resistance
skeletal muscle